The ABCs of molecular diagnostic testing of CNS tumors: acceptance, benefits, costs

Pieter Wesseling

doi:10.1093/neuonc/noz027

The ABCs of molecular diagnostic testing of CNS tumors: acceptance, benefits, costs

Pieter Wesseling

Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands
Utrecht University

Research output: Contribution to journal › Editorial › Academic › peer-review

10 Downloads (Pure)

Original language	English
Pages (from-to)	559-561
Number of pages	3
Journal	Neuro-oncology
Volume	21
Issue number	5
DOIs	https://doi.org/10.1093/neuonc/noz027
Publication status	Published - 1 May 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/neuonc/noz027

The-abcs-of-molecular-diagnostic-testing-of-cns-tumors-acceptance-benefits-costs.pdfFinal published version, 129 KBLicence: Taverne

Cite this

@article{2adc5e5e3ed84d8c8b5e2f199c9ae0ba,

title = "The ABCs of molecular diagnostic testing of CNS tumors: acceptance, benefits, costs",

author = "Pieter Wesseling",

year = "2019",

month = may,

day = "1",

doi = "10.1093/neuonc/noz027",

language = "English",

volume = "21",

pages = "559--561",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - The ABCs of molecular diagnostic testing of CNS tumors: acceptance, benefits, costs

AU - Wesseling, Pieter

PY - 2019/5/1

Y1 - 2019/5/1

UR - https://www.scopus.com/pages/publications/85065674677

U2 - 10.1093/neuonc/noz027

DO - 10.1093/neuonc/noz027

M3 - Editorial

C2 - 31059570

SN - 1522-8517

VL - 21

SP - 559

EP - 561

JO - Neuro-oncology

JF - Neuro-oncology

IS - 5

ER -

The ABCs of molecular diagnostic testing of CNS tumors: acceptance, benefits, costs

UN SDGs

Access to Document

Other files and links

Cite this